7mg Total Compounds Per Vial 10ml of Bacteriostatic Water For Reconstitution Included
Growth hormone-releasing peptide-6 (GHRP-6) is a synthetic hexapeptide analog of ghrelin, designed to act as a potent agonist at the growth hormone secretagogue receptor (GHS-R) on pituitary somatotrophs. Administered exogenously, it elicits a rapid, dose-dependent pulsatile release of endogenous growth hormone (GH), with secondary effects on adrenocorticotropic hormone (ACTH) and cortisol.
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH), modified with a drug affinity complex (DAC). This modification extends its plasma half-life to approximately 6–8 days, enabling sustained GH release compared to native GHRH.
Physiological Roles (GHRP6)
Growth Hormone Stimulation: GHRP-6 primarily induces GH secretion by mimicking ghrelin's action, promoting lipolysis, protein synthesis, and insulin-like growth factor-1 (IGF-1) production in the liver, thereby supporting anabolic processes such as muscle growth and recovery.
Appetite and Metabolic Effects: It activates hypothalamic orexigenic pathways, increasing appetite (orexigenic effect) and influencing glucose homeostasis, which may contribute to its utility in catabolic states.
Physiological Roles (CJC 1295 DAC)
Sustained GH Pulsatility: CJC-1295 DAC binds to GHRH receptors on pituitary somatotrophs, amplifying endogenous GH secretion in a more continuous manner, which enhances IGF-1 bioavailability and supports tissue repair, bone density, and metabolic regulation.
Anabolic and Anti-Aging Effects: It facilitates lipolytic and anti-catabolic actions, potentially aiding in body composition optimization, wound healing, and age-related GH decline mitigation.
Request more details about ProGrow